Business Wire

PQE Group Reports Solid Year-End Results, Strengthens Position through Innovation in Pharmaceuticals and Medical Devices

27.1.2026 15:00:00 CET | Business Wire | Press Release

Share

2025 represented another successful year for PQE Group, a consulting firm in the Life Sciences industry based in Florence (Italy) that includes more than 2000 employees and 40+ offices worldwide. Recently named "Best Managed Company" by Deloitte Private for the sixth consecutive year, the Group achieved a rise in revenue, which reached € 105 millions in 2025, an increase of 7% compared to the €97,5M millions realized in 2024.

Founded by CEO Gilda D'Incerti in 1998, PQE Group is a women-owned company that has received numerous industry certifications, including ISO/IEC 27001, which is the world's best-known standard for information security, and ISO 9001, which focuses on quality management systems. To enhance its ongoing global expansion efforts, in 2025 PQE further expanded in the APAC Region, continued to strengthen its presence in North America, and established new offices in Latina, Italy and Copenhagen, Denmark. PQE also deepened its commitment to Artificial Intelligence (AI) in 2025, focusing heavily on PQE’s AI and Cybersecurity Services excellence and allocating significant resources to stay abreast of AI technological advancements, trends, and offerings in the Life Sciences industry.

In addition to receiving Deloitte Private’s Best Managed Company 2025 Award, PQE’s achievements and recognitions throughout the year included: Great Place to Work Certification for its US Subsidiary for the fourth consecutive year; Best Life Science Company in Maryland by Stellar Business Awards; Ecovadis Badge for Sustainability Excellence 2026; and recognition among the top 75 ESG performers at the Sustainability Award 2025, receiving the 2025 Sustainability Award Italy, which recognizes PQE’s commitment to ESG, the goals of which are published in its Sustainability Report each year, thereby disclosing detailed information on PQE’s sustainability strategy.

In 2025, PQE enhanced its already knowledgeable, professional SME staff by hiring additional senior level consultants and industry experts in numerous service areas, including the recent appointment of Francesco Minà as new Vice President Operations, who, after two decades spent working in the field of Automation and Operational Excellence for Johnson & Johnson, will now lead the service delivery of PQE Group at global level.

“2025 has been a positive year for PQE Group, a private company, made in Italy, with an international dimension,” said Gilda D’Incerti, PQE Group’s CEO & Founder. “This allows us to be in competition with the biggest consulting companies,” she continued, “and not only because of our global network and substantial number of highly specialized resources. By continuously monitoring industry trends and evolving technologies, we provide high-level solutions at competitive costs, pairing local responsiveness with global expertise, and we are quickly becoming one of the top worldwide consulting companies in the biopharmaceutical and medical device industries.”

As PQE continues to expand its global network, it is very committed to investing in expertise and knowledgeable professionals, delivering innovative and impactful solutions for its clients worldwide, and giving back through meaningful social responsibility initiatives— alongside an on-going commitment to patients’ safety and constant efforts to positively enhance the Life Science industry. On this note, the company is a proud member of the EU-funded Project-COMFORT Consortium that aims to transform healthcare through Patient Centric micro-Sampling (PCmS), a minimally invasive method for collecting and analyzing blood samples outside traditional clinical settings. For this effort, PQE is currently leading the “Work Package 7: Laying the Foundation for the Future”, to engage with the project’s audiences by sharing insights, updates, and outputs such as reports and publications.

About PQE Group
Established in Florence, Italy, in 1998, PQE Group is a woman-owned leading Life Science consulting firm, providing high-quality solutions in GCP, GLP, GMP, and GDP areas to both industry giants and small-mid-size businesses worldwide. With a focus on innovation, efficiency, and sustainability and with a global presence through its 40+ offices located around the world and 2000+ professional employees, PQE Group continues to set industry benchmarks and drive positive change in the Life Science sector. The Group's CEO & Founder, Gilda D'Incerti, has also launched ReSQ-UP, a groundbreaking initiative in the Clinical Research Organizations field, focusing on supporting emerging startups in women's health (FemTech), medical devices, and innovations in the biotech sector.

Visit us at PQE Group: Home - PQE Group , and follow PQE Group on LinkedIn, Instagram and Facebook
Learn more about Project-COMFORT: Home – Project-COMFORT, and follow us on LinkedIn

View source version on businesswire.com: https://www.businesswire.com/news/home/20260127299159/en/

Contacts

PQE Group Press Office | Contacts: press@pqegroup.com

PQE Global
Debra J. Kaufmann
d.kaufmann@pqegroup.com
Mobile Phone – US : +240-704-0550

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

NIQ Expands ConnectAI Charter Program with Mars Snacking22.10.2026 12:45:00 CEST | Press Release

NielsenIQ (NYSE: NIQ), a leading consumer intelligence company, today announced Mars as a new ConnectAI Charter client, expanding the program’s growing roster of global companies working with NIQ to build the intelligence foundation for amplifying enterprise AI workflows. Through the ConnectAI Charter Program, NIQ forward-deployed engineers and data scientists are working with Mars to embed NIQ intelligence in the expansion of AI-enabled workflows across its business. The engagement focuses on connecting NIQ data, models, and business context with Mars’ AI ecosystem to help reduce the distance between data and decision-making. Together, they are tackling use cases like conversational analytics and harmonized product data to lay the foundation for future use cases. “As we expand the use of AI across our business, we see an opportunity to bring decision-makers closer to insight and reduce the manual effort between data and action," said Rishi Padhi, SVP and Chief Digital and Information

Spotlight Medical Announces Successful Independent Evaluation of Its Digital Slide-Based Test for Assessing Recurrence Risk in Early Breast Cancer22.10.2026 12:18:00 CEST | Press Release

Spotlight Medical, a company developing AI-powered prognostic tests in oncology, today announced results from an independent evaluation of myStage Dx, its CE-IVDR-marked test for assessing recurrence risk in patients with hormone receptor-positive, HER2-negative early breast cancer. The study was conducted by researchers at Karolinska Institutet in Sweden. Independent, Blinded Evaluation Using Phase III Trial Data The study used data from 620 patients enrolled in PANTHER, an international randomized phase III trial comparing dose-dense with standard chemotherapy. myStage Dxpredictions were generated blinded to clinical outcomes. Researchers at Karolinska Institutet linked the predictions to patient outcomes and independently assessed prognostic performance according to a prespecified protocol and statistical analysis plan. Within this clinically high-risk population, myStage Dx identified two groups with markedly different long-term outcomes. The Low Risk group comprised 23.5% of patie

Zoomtopia: Zoom lanserar nya AI-funktioner22.10.2026 12:14:00 CEST | Pressmeddelande

Zoom vill korta vägen från mötesbeslut till genomfört arbete. På kundkonferensen Zoomtopia presenterar företaget Unified Context Layer – ett gemensamt informationslager som kopplar ihop samtal, dokument och data så att AI kan förstå sammanhanget och hjälpa till med nästa steg. Samtidigt lanseras flera nya AI-produkter och funktioner som ska göra det enklare att omsätta diskussioner och beslut i handling. Detta pressmeddelande använder multimedia. Se den fullständiga versionen här: https://www.businesswire.com/news/home/20261021741529/sv/ I möten och samtal fattas viktiga beslut och företag får värdefulla insikter om sina kunder. Men en kunddialog kan börja i ett möte, fortsätta på telefon och sedan övergå i en chatt. När information sprids mellan olika verktyg blir det svårt för både medarbetare och AI-agenter att få en samlad bild av vad som har sagts och beslutats. Resultatet blir att värdefull tid går åt till att ta reda på vad som har sagts och beslutats och vad som behöver göras h

TACTICA AI and NVIDIA Collaborate to Scale Agentic AI Capabilities with NVIDIA Nemotron22.10.2026 12:01:00 CEST | Press Release

TACTICAAI, an operational decision-intelligence company, today announced a collaboration with NVIDIA to advance and scale the deployment of agentic AI capabilities. The companies will work together to integrate and optimize NVIDIA Nemotron models within TACTICAAI’s multi-intelligence platform, with a focus on expanding these capabilities and supporting deployment with major customers internationally. The collaboration was announced at NVIDIA GTC Berlin. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022054475/en/ TACTICA AI and NVIDIA Collaborate to Scale Agentic AI Capabilities with NVIDIA Nemotron (Graphic: AETOSWire) The collaboration with NVIDIA builds on the company’s existing technology, integrating selected NVIDIA AI models and tools to further enhance capabilities across advanced reasoning, autonomous analysis and video intelligence. The integration allows TACTICAAI to draw on NVIDIA’s AI ecosystem while maintaini

BeOne Medicines to Announce Third Quarter 2026 Financial Results on November 522.10.2026 12:01:00 CEST | Press Release

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its third quarter 2026 financial results on Thursday, November 5, 2026, before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com.To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company that is discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The Company has

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye